MedPath

Sevelamer

Generic Name
Sevelamer
Brand Names
Renagel, Renvela, Sevelamer carbonate Winthrop (previously Sevelamer carbonate Zentiva)
Drug Type
Small Molecule
Chemical Formula
C6H12ClNO
CAS Number
52757-95-6
Unique Ingredient Identifier
941N5DUU5C

Overview

Sevelamer is a phosphate binding drug used to prevent hyperphosphataemia in patients with chronic renal failure. It is marketed by Genzyme under the trade name Renagel.

Background

Sevelamer is a phosphate binding drug used to prevent hyperphosphataemia in patients with chronic renal failure. It is marketed by Genzyme under the trade name Renagel.

Indication

For the control of serum phosphorus in patients with Chronic Kidney Disease (CKD) on hemodialysis.

Associated Conditions

  • Hyperphosphataemia

FDA Approved Products

SEVELAMER HYDROCHLORIDE
Manufacturer:Aurobindo Pharma Limited
Route:ORAL
Strength:800 mg in 1 1
Approved: 2024/01/24
NDC:59651-088
Sevelamer Carbonate
Manufacturer:Amneal Pharmaceuticals LLC
Route:ORAL
Strength:800 mg in 1 1
Approved: 2024/02/05
NDC:65162-058
Sevelamer Carbonate
Manufacturer:American Health Packaging
Route:ORAL
Strength:800 mg in 1 1
Approved: 2022/06/28
NDC:60687-328
Sevelamer Carbonate for Oral Suspension
Manufacturer:Dr. Reddys Laboratories Inc
Route:ORAL
Strength:2400 mg in 1 1
Approved: 2017/09/29
NDC:43598-479
Sevelamer Carbonate for Oral Suspension
Manufacturer:Dr. Reddys Laboratories Inc
Route:ORAL
Strength:800 mg in 1 1
Approved: 2017/09/29
NDC:43598-478

Singapore Approved Products

Renvela ® Tablet 800mg
Manufacturer:Sanofi Winthrop Industrie
Form:TABLET, FILM COATED
Strength:800 mg
Online:Yes
Approved: 2009/11/06
Approval:SIN13725P
SEVELA FILM COATED TABLET 800MG
Manufacturer:Chen Ho Pharmaceutical Co., Ltd. Sinying Plant
Form:TABLET, FILM COATED
Strength:800mg
Online:Yes
Approved: 2021/02/16
Approval:SIN16105P
CAVSAMIR FILM COATED TABLET 800MG
Manufacturer:Dr. Reddy's Laboratories Limited
Form:TABLET, FILM COATED
Strength:800 mg
Online:Yes
Approved: 2024/04/26
Approval:SIN16993P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath